These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 8898414

  • 1. Gastro-oesophageal reflux during 3 months of therapy with ranitidine in reflux oesophagitis.
    Hatlebakk JG, Berstad A.
    Scand J Gastroenterol; 1996 Oct; 31(10):954-8. PubMed ID: 8898414
    [Abstract] [Full Text] [Related]

  • 2. Gastro-oesophageal reflux disease in The Netherlands. Results of a multicentre pH study.
    Smout AJ, Geus WP, Mulder PG, Stockbrügger RW, Lamers CB.
    Scand J Gastroenterol Suppl; 1996 Oct; 218():10-5. PubMed ID: 8865445
    [Abstract] [Full Text] [Related]

  • 3. Primary gastro-oesophageal reflux disease and irritable oesophagus syndrome as causes of recurrent abdominal pain in children.
    Corrado G, Cavaliere M, Frandina G, Rea P, Pacchiarotti C, Capocaccia P, Cardi E.
    Ital J Gastroenterol; 1996 Oct; 28(8):462-9. PubMed ID: 9032590
    [Abstract] [Full Text] [Related]

  • 4. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.
    Inauen W, Emde C, Weber B, Armstrong D, Bettschen HU, Huber T, Scheurer U, Blum AL, Halter F, Merki HS.
    Gut; 1993 Aug; 34(8):1025-31. PubMed ID: 8174947
    [Abstract] [Full Text] [Related]

  • 5. [Effect of oxmetidine and ranitidine on reflux behavior in patients with esophagitis].
    Weiser HF, Gubernatis G, Siewert JR.
    Z Gastroenterol; 1983 Oct; 21(10):580-4. PubMed ID: 6139923
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG, Berstad A.
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The efficacy of omeprazole twice daily with supplemental H2 blockade at bedtime in the suppression of nocturnal oesophageal and gastric acidity.
    Orr WC, Harnish MJ.
    Aliment Pharmacol Ther; 2003 Jun 15; 17(12):1553-8. PubMed ID: 12823159
    [Abstract] [Full Text] [Related]

  • 15. A dose-ranging study of ranitidine and its effect on intragastric and intra-oesophageal acidity in subjects with gastro-oesophageal reflux disease.
    Thomson AB, Babiuk L, Kirdeikis P, Zuk L, Marriage B, Bowes K.
    Aliment Pharmacol Ther; 1994 Aug 15; 8(4):443-51. PubMed ID: 7986969
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis.
    Fiorucci S, Santucci L, Morelli A.
    Am J Gastroenterol; 1990 Nov 15; 85(11):1458-62. PubMed ID: 2239873
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Patterns of 24-hour oesophageal acid exposure after acute withdrawal of acid suppression.
    Orr WC, Mellow MH, Grossman MR.
    Aliment Pharmacol Ther; 1995 Oct 15; 9(5):571-4. PubMed ID: 8580280
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.